BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Witteloostuijn SB, Pedersen SL, Jensen KJ. Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation. ChemMedChem 2016;11:2474-95. [DOI: 10.1002/cmdc.201600374] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Esposito S, Krick A, Pasquier O, Bonche F, Ingenito R, Magotti P, Bianchi E, Monteagudo E, Gallo M, Cicero DO, Orsatti L, Veneziano M, Caretti F, Mele R, Roversi D, Gennari N, Brasseur D, Gauzy-lazo L, Duclos O, Mauriac C, Illiano S, Mallart S. Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species. Journal of Pharmaceutical and Biomedical Analysis 2023. [DOI: 10.1016/j.jpba.2023.115256] [Reference Citation Analysis]
2 Wang S, Wang X, Teng X, Dai J, Dong Y, Yuan H, Xiu Z. Fatty acid chain modification of loxenatide and its kinetics in a continuous flow microchannel reactor. Process Biochemistry 2023;124:259-268. [DOI: 10.1016/j.procbio.2022.12.007] [Reference Citation Analysis]
3 Liu Y, Bai X, Lyu C, Fang J, Zhang F, Wu WH, Wei W, Zhang WB. Mechano-bioconjugation Strategy Empowering Fusion Protein Therapeutics with Aggregation Resistance, Prolonged Circulation, and Enhanced Antitumor Efficacy. J Am Chem Soc 2022. [PMID: 36178288 DOI: 10.1021/jacs.2c06532] [Reference Citation Analysis]
4 Crystal Chan SH, Griffin JM, Clemett CA, Brimble MA, O’carroll SJ, Harris PWR. Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5. Front Chem 2022;10:877618. [DOI: 10.3389/fchem.2022.877618] [Reference Citation Analysis]
5 Wong J, Kirberger S, Qiu R, Ekanayake A, Kelich P, Sarkar S, Alvizo-paez E, Miao J, Kalhor-monfared S, Dwyer J, Nuss J, Lin Y, Macauley M, Vukovic L, Pomerantz W, Derda R. Genetically-Encoded Discovery of Perfluoroaryl-Macrocycles that Bind to Albumin and Exhibit Extended Circulation in-vivo.. [DOI: 10.21203/rs.3.rs-1999287/v1] [Reference Citation Analysis]
6 Esposito S Dr, Orsatti L Dr, Pucci V Dr. Subcutaneous Catabolism of Peptide Therapeutics: Bioanalytical Approaches and ADME Considerations. Xenobiotica 2022;:1-35. [PMID: 36039395 DOI: 10.1080/00498254.2022.2119180] [Reference Citation Analysis]
7 Xu L, Guan R, Yu B, Li Y, Liu H, Jiang Y. Fluorene methoxycarbonyl-PEG-deferoxamine conjugates "hitchhike" with albumin in situ for iron overload therapy. Int J Pharm 2022;625:122136. [PMID: 36029994 DOI: 10.1016/j.ijpharm.2022.122136] [Reference Citation Analysis]
8 Wong JY, Kirberger SE, Qiu R, Ekanayake AI, Kelich P, Sarkar S, Alvizo-paez ER, Miao J, Kalhor-monfared S, Dwyer JJ, Nuss JM, Lin Y, Macauley MS, Vukovic L, Pomerantz WC, Derda R. Genetically-Encoded Discovery of Perfluoroaryl-Macrocycles that Bind to Albumin and Exhibit Extended Circulation in-vivo.. [DOI: 10.1101/2022.08.22.504611] [Reference Citation Analysis]
9 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
10 Hung K, Kowalczyk R, Desai A, Brimble MA, Marshall JF, Harris PWR. Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma. Molecules 2022;27:4331. [DOI: 10.3390/molecules27144331] [Reference Citation Analysis]
11 Yang B, Gomes Dos Santos A, Puri S, Bak A, Zhou L. The industrial design, translation, and development strategies for long-acting peptide delivery. Expert Opin Drug Deliv 2022. [PMID: 35787229 DOI: 10.1080/17425247.2022.2098276] [Reference Citation Analysis]
12 Zagkou S, Marais V, Zeghoudi N, Guillou EL, Eskelinen E, Panasyuk G, Verrier B, Primard C. Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation. Pharmaceutics 2022;14:1379. [DOI: 10.3390/pharmaceutics14071379] [Reference Citation Analysis]
13 Wang SC, Teng XN, Wang XD, Dong YS, Yuan HL, Xiu ZL. Recycling reaction and separation for FACylation of loxenatide by trade-off between miscibility and immiscibility of reactants and product in methanol solution. J Chromatogr A 2022;1676:463239. [PMID: 35709607 DOI: 10.1016/j.chroma.2022.463239] [Reference Citation Analysis]
14 Weißenborn L, Richel E, Hüseman H, Welzer J, Beck S, Schäfer S, Sticht H, Überla K, Eichler J. Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein. Int J Mol Sci 2022;23:6309. [PMID: 35682988 DOI: 10.3390/ijms23116309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zheng Y, Cong Y, Schmidt EW, Nair SK. Catalysts for the Enzymatic Lipidation of Peptides. Acc Chem Res 2022;55:1313-23. [PMID: 35442036 DOI: 10.1021/acs.accounts.2c00108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Danielsen M, Hempel C, Andresen TL, Urquhart AJ. Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics. J Control Release 2022:S0168-3659(22)00246-2. [PMID: 35513210 DOI: 10.1016/j.jconrel.2022.04.050] [Reference Citation Analysis]
17 Hu X, Tang BZ. Activated Alkynes in Metal‐free Bioconjugation. Handbook of Aggregation‐Induced Emission 2022. [DOI: 10.1002/9781119643098.ch37] [Reference Citation Analysis]
18 Wijesinghe A, Kumari S, Booth V. Conjugates for use in peptide therapeutics: A systematic review and meta-analysis. PLoS One 2022;17:e0255753. [PMID: 35259149 DOI: 10.1371/journal.pone.0255753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Jiang M, Zhao J, Mei G, Lin H, Hong H, Li D, Wu Z. Chemoenzymatic synthesis of 6′-sialolactose-modified nanobody. Journal of Carbohydrate Chemistry. [DOI: 10.1080/07328303.2022.2055048] [Reference Citation Analysis]
20 Raganato L, Del Giudice A, Ceccucci A, Sciubba F, Casciardi S, Sennato S, Scipioni A, Masci G. Self-assembling nanowires from a linear l,d-peptide conjugated to the dextran end group. Int J Biol Macromol 2022;207:656-65. [PMID: 35292281 DOI: 10.1016/j.ijbiomac.2022.03.050] [Reference Citation Analysis]
21 Alexopoulou F, Bech EM, Pedersen SL, Thorbek DD, Leurs U, Rudkjær LCB, Fosgerau K, Hansen HH, Vrang N, Jelsing J, Elster L. Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect. Sci Rep 2022;12:1696. [PMID: 35105898 DOI: 10.1038/s41598-022-05310-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vanderschuren K, Arranz-Gibert P, Khang M, Hadar D, Gaudin A, Yang F, Folta-Stogniew E, Saltzman WM, Amiram M, Isaacs FJ. Tuning protein half-life in mouse using sequence-defined biopolymers functionalized with lipids. Proc Natl Acad Sci U S A 2022;119:e2103099119. [PMID: 35046019 DOI: 10.1073/pnas.2103099119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
23 Engudar G, Rodríguez-Rodríguez C, Mishra NK, Bergamo M, Amouroux G, Jensen KJ, Saatchi K, Häfeli UO. Metal-ion coordinated self-assembly of human insulin directs kinetics of insulin release as determined by preclinical SPECT/CT imaging. J Control Release 2022:S0168-3659(22)00046-3. [PMID: 35085699 DOI: 10.1016/j.jconrel.2022.01.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sakamoto K, Furukawa H, Arafiles JVV, Imanishi M, Matsuura K, Futaki S. Artificial Nanocage Formed via Self-Assembly of β-Annulus Peptide for Delivering Biofunctional Proteins into Cell Interiors. Bioconjug Chem 2022. [PMID: 35049280 DOI: 10.1021/acs.bioconjchem.1c00534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Xu YD, Tian L, Lai RY, Li Z, Procházková E, Ho J, Stenzel MH. Development of an Albumin–Polymer Bioconjugate via Covalent Conjugation and Supramolecular Interactions. Bioconjugate Chem . [DOI: 10.1021/acs.bioconjchem.1c00536] [Reference Citation Analysis]
26 Hori K, Yoshimoto S, Yoshino T, Zako T, Hirao G, Fujita S, Nakamura C, Yamagishi A, Kamiya N. Recent advances in research on biointerfaces: From cell surfaces to artificial interfaces. J Biosci Bioeng 2022:S1389-1723(21)00331-5. [PMID: 34998688 DOI: 10.1016/j.jbiosc.2021.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hasan M, Stratford RE. Biopharmaceutical Drug Products: An Overview of Physicochemical Properties and Their Modification. The ADME Encyclopedia 2022. [DOI: 10.1007/978-3-030-84860-6_19] [Reference Citation Analysis]
28 Jiang H, Chen W, Wang J, Zhang R. Selective N-terminal modification of peptides and proteins: Recent progresses and applications. Chinese Chemical Letters 2022;33:80-8. [DOI: 10.1016/j.cclet.2021.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 Jensen KB, Mikkelsen JH, Jensen SP, Kidal S, Friberg G, Skrydstrup T, Gustafsson MBF. New Phenol Esters for Efficient pH-Controlled Amine Acylation of Peptides, Proteins, and Sepharose Beads in Aqueous Media. Bioconjug Chem 2021. [PMID: 34962390 DOI: 10.1021/acs.bioconjchem.1c00528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Yin S, Zhang B, Lin J, Liu Y, Su Z, Bi J. Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation. Eng Life Sci 2021;21:630-42. [PMID: 34690634 DOI: 10.1002/elsc.202000105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu F, Ul Amin T, Liang D, Park MS, Alhamadsheh MM. Enhancing the Pharmacokinetic Profile of Interleukin 2 through Site-Specific Conjugation to a Selective Small-Molecule Transthyretin Ligand. J Med Chem 2021;64:14876-86. [PMID: 34542267 DOI: 10.1021/acs.jmedchem.1c01426] [Reference Citation Analysis]
32 Talkington AM, McSweeney MD, Zhang T, Li Z, Nyborg AC, LaMoreaux B, Livingston EW, Frank JE, Yuan H, Lai SK. High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies. J Control Release 2021;338:804-12. [PMID: 34481925 DOI: 10.1016/j.jconrel.2021.08.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Hirai Y, Hirose H, Imanishi M, Asai T, Futaki S. Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles. Sci Rep 2021;11:19896. [PMID: 34615928 DOI: 10.1038/s41598-021-99180-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sánchez-Trasviña C, Flores-Gatica M, Enriquez-Ochoa D, Rito-Palomares M, Mayolo-Deloisa K. Purification of Modified Therapeutic Proteins Available on the Market: An Analysis of Chromatography-Based Strategies. Front Bioeng Biotechnol 2021;9:717326. [PMID: 34490225 DOI: 10.3389/fbioe.2021.717326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ruan S, Yang G, Dong Y, Shangguan W, Lu W. Discovery of a Long-Acting Parathyroid Hormone 1-34 Analogue to Treat Hypoparathyroidism. Mol Pharm 2021;18:3260-71. [PMID: 34482698 DOI: 10.1021/acs.molpharmaceut.1c00149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Wijesinghe A, Kumari S, Booth V. Conjugates for use in peptide therapeutics: a systematic review and meta-analysis.. [DOI: 10.1101/2021.08.05.455324] [Reference Citation Analysis]
37 Le QV, Lee J, Lee H, Shim G, Oh YK. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharm Sin B 2021;11:2096-113. [PMID: 34522579 DOI: 10.1016/j.apsb.2021.01.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
38 Schneider H, Englert S, Macarrón Palacios A, Lerma Romero JA, Ali A, Avrutina O, Kolmar H. Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro. Front Chem 2021;9:693097. [PMID: 34368077 DOI: 10.3389/fchem.2021.693097] [Reference Citation Analysis]
39 Bunzen H. Chemical Stability of Metal‐organic Frameworks for Applications in Drug Delivery. ChemNanoMat 2021;7:998-1007. [DOI: 10.1002/cnma.202100226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
40 Maese L, Rizzari C, Coleman R, Power A, van der Sluis I, Rau RE. Can recombinant technology address asparaginase Erwinia chrysanthemi shortages? Pediatr Blood Cancer 2021;68:e29169. [PMID: 34105243 DOI: 10.1002/pbc.29169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Elshiaty M, Schindler H, Christopoulos P. Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer. Int J Mol Sci 2021;22:5632. [PMID: 34073188 DOI: 10.3390/ijms22115632] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
42 Della Pelle G, Kostevšek N. Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers. Int J Mol Sci 2021;22:5264. [PMID: 34067699 DOI: 10.3390/ijms22105264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Mishra NK, Østergaard M, Midtgaard SR, Strindberg SS, Winkler S, Wu S, Sørensen TJ, Hassenkam T, Poulsen JN, Lo Leggio L, Nielsen HM, Arleth L, Christensen NJ, Thulstrup PW, Jensen KJ. Controlling the fractal dimension in self-assembly of terpyridine modified insulin by Fe2+ and Eu3+ to direct in vivo effects. Nanoscale 2021;13:8467-73. [PMID: 33984105 DOI: 10.1039/d1nr00414j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zhang Q, Ruan S, Wu Y, Zhang J, Lu J, Feng J. Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids. Pharmaceutical Fronts 2021;02:e160-7. [DOI: 10.1055/s-0041-1728817] [Reference Citation Analysis]
45 Tully M, Wedepohl S, Kutifa D, Weise C, Licha K, Schirner M, Haag R. Prolonged activity of exenatide: Detailed comparison of Site-specific linear polyglycerol- and poly(ethylene glycol)-conjugates. Eur J Pharm Biopharm 2021;164:105-13. [PMID: 33957224 DOI: 10.1016/j.ejpb.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Sellner J, Sitte HH, Rommer PS. Targeting interleukin-6 to treat neuromyelitis optica spectrum disorders: Implications from immunology, the FcRn pathway and clinical experience. Drug Discov Today 2021;26:1591-601. [PMID: 33781948 DOI: 10.1016/j.drudis.2021.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Kaps A, Gwiazdoń P, Chodurek E. Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies. Molecules 2021;26:1764. [PMID: 33801096 DOI: 10.3390/molecules26061764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
48 Chouchane L, Grivel JC, Farag EABA, Pavlovski I, Maacha S, Sathappan A, Al-Romaihi HE, Abuaqel SW, Ata MMA, Chouchane AI, Remadi S, Halabi N, Rafii A, Al-Thani MH, Marr N, Subramanian M, Shan J. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2. JCI Insight 2021;6:145785. [PMID: 33529170 DOI: 10.1172/jci.insight.145785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
49 Qian M, Zhang Q, Lu J, Zhang J, Wang Y, Shangguan W, Feng M, Feng J. Long-Acting Human Interleukin 2 Bioconjugate Modified with Fatty Acids by Sortase A. Bioconjug Chem 2021;32:615-25. [PMID: 33656323 DOI: 10.1021/acs.bioconjchem.1c00062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Saadi S, Ghazali HM, Saari N, Abdulkarim SM. The structural reconformation of peptides in enhancing functional and therapeutic properties: Insights into their solid state crystallizations. Biophys Chem 2021;273:106565. [PMID: 33780688 DOI: 10.1016/j.bpc.2021.106565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Lee CH, Lou YC, Wang AH. DMTMM-Mediated Intramolecular Cyclization of Acidic Residues in Peptides/Proteins. ACS Omega 2021;6:4708-18. [PMID: 33644578 DOI: 10.1021/acsomega.0c05503] [Reference Citation Analysis]
52 Vantourout JC, Mason AM, Yuen J, Simpson GL, Evindar G, Kuai L, Hobbs M, Edgar E, Needle S, Bai X, Wilson S, Scott-Stevens P, Traylen W, Lambert K, Young N, Bunally S, Summerfield SG, Snell R, Lad R, Shi E, Skinner S, Shewchuk L, Watson AJB, Chung CW, Pal S, Holt DA, Kallander LS, Prendergast J, Rivera K, Washburn DG, Harpel MR, Arico-Muendel C, Isidro-Llobet A. In Vivo Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin Binders. Bioconjug Chem 2021;32:279-89. [PMID: 33523652 DOI: 10.1021/acs.bioconjchem.0c00662] [Reference Citation Analysis]
53 Cao S, Lv Z, Guo S, Jiang G, Liu H. An update - Prolonging the action of protein and peptide drugs. Journal of Drug Delivery Science and Technology 2021;61:102124. [DOI: 10.1016/j.jddst.2020.102124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Becker B, Englert S, Schneider H, Yanakieva D, Hofmann S, Dombrowsky C, Macarrón Palacios A, Bitsch S, Elter A, Meckel T, Kugler B, Schirmacher A, Avrutina O, Diederichsen U, Kolmar H. Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoes. J Pept Sci 2021;27:e3298. [PMID: 33458922 DOI: 10.1002/psc.3298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Lembke W, Locher M. Monoclonal Antibodies: Discovery and Protein Engineering. Regulatory Toxicology 2021. [DOI: 10.1007/978-3-030-57499-4_148] [Reference Citation Analysis]
56 Lembke W, Locher M. Monoclonal Antibodies: Discovery and Protein Engineering. Regulatory Toxicology 2021. [DOI: 10.1007/978-3-642-36206-4_148-1] [Reference Citation Analysis]
57 Deng Y, Wang X, Liu Y, Xu Y, Zhang J, Huang F, Li B, Miao Y, Sun Y, Li Y. Dual-light triggered metabolizable nano-micelles for selective tumor-targeted photodynamic/hyperthermia therapy. Acta Biomater 2021;119:323-36. [PMID: 33122146 DOI: 10.1016/j.actbio.2020.10.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
58 Hasan M, Stratford RE. Biopharmaceutical Drug Products: An Overview of Physicochemical Properties and Their Modification. The ADME Encyclopedia 2021. [DOI: 10.1007/978-3-030-51519-5_19-1] [Reference Citation Analysis]
59 Wu Y, Williams J, Calder EDD, Walport LJ. Strategies to expand peptide functionality through hybridisation with a small molecule component. RSC Chem Biol 2021;2:151-65. [PMID: 34458778 DOI: 10.1039/d0cb00167h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Kalomoiri P, Rodríguez-Rodríguez C, Sørensen KK, Bergamo M, Saatchi K, Häfeli UO, Jensen KJ. Bioimaging and Biodistribution of the Metal-Ion-Controlled Self-Assembly of PYY3-36 Studied by SPECT/CT. Chembiochem 2020;21:3338-48. [PMID: 32667131 DOI: 10.1002/cbic.202000266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
61 Deng Y, Huang F, Zhang J, Liu J, Li B, Ouyang R, Miao Y, Sun Y, Li Y. PEGylated iridium-based nano-micelle: Self-assembly, selective tumor fluorescence imaging and photodynamic therapy. Dyes and Pigments 2020;182:108651. [DOI: 10.1016/j.dyepig.2020.108651] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
62 Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw PT, Williams GR, Brocchini S, Awwad S. Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 2020;12:E999. [PMID: 33096803 DOI: 10.3390/pharmaceutics12100999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
63 Miki G, Kuroishi N, Tokashiki M, Nagata S, Tamura M, Yoshiya T, Yoshizawa-kumagaye K, Ashizuka S, Kato J, Yamasaki M, Kitamura K. 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease. GastrointestDisord 2020;2:366-77. [DOI: 10.3390/gidisord2040033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Rahimizadeh P, Yang S, Lim SI. Albumin: An Emerging Opportunity in Drug Delivery. Biotechnol Bioproc E 2020;25:985-95. [DOI: 10.1007/s12257-019-0512-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
65 Ding Y, Ting JP, Liu J, Al-Azzam S, Pandya P, Afshar S. Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics. Amino Acids 2020;52:1207-26. [PMID: 32945974 DOI: 10.1007/s00726-020-02890-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
66 Mickiene G, Dalgėdienė I, Zvirblis G, Dapkunas Z, Plikusiene I, Buzavaite-Verteliene E, Balevičius Z, Rukšėnaitė A, Pleckaityte M. Human granulocyte-colony stimulating factor (G-CSF)/stem cell factor (SCF) fusion proteins: design, characterization and activity. PeerJ 2020;8:e9788. [PMID: 32884863 DOI: 10.7717/peerj.9788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Yazaki P, Lwin T, Minnix M, Li L, Sherman A, Molnar J, Miller A, Frankel P, Chea J, Poku E, Bowles N, Hoffman R, Shively J, Bouvet M. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors. J Biomed Opt 2019;24:1-9. [PMID: 31254333 DOI: 10.1117/1.JBO.24.6.066012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
68 Palanikumar L, Al-Hosani S, Kalmouni M, Saleh HO, Magzoub M. Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mimic for Cancer-Selective Cytotoxicity. Biochemistry 2020;59:2259-73. [PMID: 32491855 DOI: 10.1021/acs.biochem.0c00141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Li B, Yuan Z, Jain P, Hung HC, He Y, Lin X, McMullen P, Jiang S. De novo design of functional zwitterionic biomimetic material for immunomodulation. Sci Adv 2020;6:eaba0754. [PMID: 32523997 DOI: 10.1126/sciadv.aba0754] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
70 Amatya R, Park T, Hwang S, Yang J, Lee Y, Cheong H, Moon C, Kwak HD, Min KA, Shin MC. Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides. Toxins (Basel) 2020;12:E313. [PMID: 32397648 DOI: 10.3390/toxins12050313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Lacroix A, Fakih HH, Sleiman HF. Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake. J Control Release 2020;324:34-46. [PMID: 32330572 DOI: 10.1016/j.jconrel.2020.04.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
72 Wenskowsky L, Wagner M, Reusch J, Schreuder H, Matter H, Opatz T, Petry SM. Resolving Binding Events on the Multifunctional Human Serum Albumin. ChemMedChem 2020;15:738-43. [PMID: 32162429 DOI: 10.1002/cmdc.202000069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
73 Palanikumar L, Al-Hosani S, Kalmouni M, Nguyen VP, Ali L, Pasricha R, Barrera FN, Magzoub M. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun Biol 2020;3:95. [PMID: 32127636 DOI: 10.1038/s42003-020-0817-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 27.3] [Reference Citation Analysis]
74 Schmid AS, Neri D. Advances in antibody engineering for rheumatic diseases. Nat Rev Rheumatol 2019;15:197-207. [PMID: 30814691 DOI: 10.1038/s41584-019-0188-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
75 Jiwani SI, Huang S, Beji O, Gyasi-Antwi P, Gillis RB, Adams GG. Clinically Relevant Insulin Degludec and its Interaction with Polysaccharides: A Biophysical Examination. Polymers (Basel) 2020;12:E390. [PMID: 32050432 DOI: 10.3390/polym12020390] [Reference Citation Analysis]
76 Berkowitz SA. Challenges with the biophysical characterization of complex (multi-chain assembly, chemically modified, big and high concentration) biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals 2020. [DOI: 10.1016/b978-0-444-64173-1.00015-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Ezban M, Hansen M, Kjalke M. An overview of turoctocog alfa pegol (N8-GP; ESPEROCT® ) assay performance: Implications for postadministration monitoring. Haemophilia 2020;26:156-63. [PMID: 31809565 DOI: 10.1111/hae.13897] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
78 Tan H, Su W, Zhang W, Wang P, Sattler M, Zou P. Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins. Curr Pharm Des 2018;24:4932-46. [PMID: 30727869 DOI: 10.2174/1381612825666190206105232] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
79 Hoey RJ, Eom H, Horn JR. Structure and development of single domain antibodies as modules for therapeutics and diagnostics. Exp Biol Med (Maywood) 2019;244:1568-76. [PMID: 31594404 DOI: 10.1177/1535370219881129] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
80 Schneider H, Yanakieva D, Macarrón A, Deweid L, Becker B, Englert S, Avrutina O, Kolmar H. TRAIL‐Inspired Multivalent Dextran Conjugates Efficiently Induce Apoptosis upon DR5 Receptor Clustering. ChemBioChem 2019;20:3006-12. [DOI: 10.1002/cbic.201900251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
81 Sternebring O, Gabel-Jensen C, Jacobsen H, Benie AJ, Bjørnsdottir I. Steady-State Plasma Concentrations of Polyethylene Glycol (PEG) are Reached in Children and Adults During Once-Weekly Prophylactic Treatment with Nonacog Beta Pegol (N9-GP). BioDrugs 2019;33:673-81. [PMID: 31549312 DOI: 10.1007/s40259-019-00380-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
82 Jung SJ, Nguyen NT, Lee SA, Seo SH, Choi E, Lee HW, Seong GH, Bae ON, Lee E. In-vivo half-life and hypoglycemic bioactivity of a fusion protein of exenatide and elastin-based polypeptide from recombinant Saccharomyces cerevisiae. Journal of Biotechnology 2019;303:16-24. [DOI: 10.1016/j.jbiotec.2019.06.304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Hrubý M, Štěpánek P, Pánek J. Physico‐Chemical Properties as a Key Factor in Choosing Practically Applicable Biocompatible Polymers. Macromol Symp 2019;386:1800241. [DOI: 10.1002/masy.201800241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Bech EM, Kaiser A, Bellmann-sickert K, Nielsen SS, Sørensen KK, Elster L, Hatzakis N, Pedersen SL, Beck-sickinger AG, Jensen KJ. Half-Life Extending Modifications of Peptide YY 3–36 Direct Receptor-Mediated Internalization. Mol Pharmaceutics 2019;16:3665-77. [DOI: 10.1021/acs.molpharmaceut.9b00554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
85 Pei D, Hu J, Rao C, Yu P, Xu H, Wang J. Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion Protein. Int J Med Sci 2019;16:1032-41. [PMID: 31341417 DOI: 10.7150/ijms.34365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Zorzi A, Linciano S, Angelini A. Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics. Medchemcomm 2019;10:1068-81. [PMID: 31391879 DOI: 10.1039/c9md00018f] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 17.8] [Reference Citation Analysis]
87 Qi F, Qi J, Hu C, Shen L, Yu W, Hu T. Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics. International Journal of Biological Macromolecules 2019;131:896-904. [DOI: 10.1016/j.ijbiomac.2019.03.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
88 Hirasawa S, Kitahara Y, Okamatsu Y, Fujii T, Nakayama A, Ueno S, Ijichi C, Futaki F, Nakata K, Taki M. Facile and Efficient Chemoenzymatic Semisynthesis of Fc-Fusion Compounds for Half-Life Extension of Pharmaceutical Components. Bioconjug Chem 2019;30:2323-31. [PMID: 31038930 DOI: 10.1021/acs.bioconjchem.9b00235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
89 Datta-Mannan A. Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides. Drug Metab Dispos 2019;47:1100-10. [PMID: 31043438 DOI: 10.1124/dmd.119.086488] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
90 Schneider H, Deweid L, Pirzer T, Yanakieva D, Englert S, Becker B, Avrutina O, Kolmar H. Dextramabs: A Novel Format of Antibody-Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold. ChemistryOpen 2019;8:354-7. [PMID: 30976476 DOI: 10.1002/open.201900066] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
91 Zaman R, Islam RA, Ibnat N, Othman I, Zaini A, Lee CY, Chowdhury EH. Current strategies in extending half-lives of therapeutic proteins. J Control Release 2019;301:176-89. [PMID: 30849445 DOI: 10.1016/j.jconrel.2019.02.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 19.5] [Reference Citation Analysis]
92 Lear S, Amso Z, Shen W. Engineering PEG-fatty acid stapled, long-acting peptide agonists for G protein-coupled receptors. Methods in Enzymology 2019. [DOI: 10.1016/bs.mie.2019.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
93 Hu X, Zhao X, He B, Zhao Z, Zheng Z, Zhang P, Shi X, Kwok RTK, Lam JWY, Qin A, Tang BZ. A Simple Approach to Bioconjugation at Diverse Levels: Metal-Free Click Reactions of Activated Alkynes with Native Groups of Biotargets without Prefunctionalization. Research (Wash D C) 2018;2018:3152870. [PMID: 31549027 DOI: 10.1155/2018/3152870] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
94 Torres MDT, Pedron CN, Higashikuni Y, Kramer RM, Cardoso MH, Oshiro KGN, Franco OL, Silva Junior PI, Silva FD, Oliveira Junior VX, Lu TK, de la Fuente-Nunez C. Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates. Commun Biol 2018;1:221. [PMID: 30534613 DOI: 10.1038/s42003-018-0224-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 14.4] [Reference Citation Analysis]
95 Farhadi SA, Bracho-Sanchez E, Fettis MM, Seroski DT, Freeman SL, Restuccia A, Keselowsky BG, Hudalla GA. Locally anchoring enzymes to tissues via extracellular glycan recognition. Nat Commun 2018;9:4943. [PMID: 30467349 DOI: 10.1038/s41467-018-07129-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
96 Han J, Huang Y, Chen X, Zhou F, Fei Y, Fu J. Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon-like peptide 1 analogues with potent and long-acting hypoglycemic activity. European Journal of Pharmaceutical Sciences 2018;123:111-23. [DOI: 10.1016/j.ejps.2018.07.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
97 Hägglund P, Mariotti M, Davies MJ. Identification and characterization of protein cross-links induced by oxidative reactions. Expert Review of Proteomics 2018;15:665-81. [DOI: 10.1080/14789450.2018.1509710] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
98 Martos-Maldonado MC, Hjuler CT, Sørensen KK, Thygesen MB, Rasmussen JE, Villadsen K, Midtgaard SR, Kol S, Schoffelen S, Jensen KJ. Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence. Nat Commun 2018;9:3307. [PMID: 30120230 DOI: 10.1038/s41467-018-05695-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
99 Liu X, Sun M, Sun J, Hu J, Wang Z, Guo J, Gao W. Polymerization Induced Self-Assembly of a Site-Specific Interferon α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology. J Am Chem Soc 2018;140:10435-8. [DOI: 10.1021/jacs.8b06013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
100 Mullican SE, Rangwala SM. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond. Trends in Endocrinology & Metabolism 2018;29:560-70. [DOI: 10.1016/j.tem.2018.05.002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 15.0] [Reference Citation Analysis]
101 Zhou H, Yang R, Wang W, Xu F, Xi Y, Brown RA, Zhang H, Shi L, Zhu D, Gong DW. Fc-apelin fusion protein attenuates lipopolysaccharide-induced liver injury in mice. Sci Rep 2018;8:11428. [PMID: 30061611 DOI: 10.1038/s41598-018-29491-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
102 Bech EM, Pedersen SL, Jensen KJ. Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives. ACS Med Chem Lett 2018;9:577-80. [PMID: 30034579 DOI: 10.1021/acsmedchemlett.8b00226] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 13.4] [Reference Citation Analysis]
103 Mickiene G, Dalgediene I, Dapkunas Z, Zvirblis G, Pesliakas H, Kaupinis A, Valius M, Mistiniene E, Pleckaityte M. Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor. Mol Biotechnol 2017;59:374-84. [PMID: 28721592 DOI: 10.1007/s12033-017-0026-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
104 Debordeaux F, Chansel-debordeaux L, Pinaquy J, Fernandez P, Schulz J. What about αvβ3 integrins in molecular imaging in oncology? Nuclear Medicine and Biology 2018;62-63:31-46. [DOI: 10.1016/j.nucmedbio.2018.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
105 Li Y, Clark KA, Tan Z. Methods for engineering therapeutic peptides. Chinese Chemical Letters 2018;29:1074-8. [DOI: 10.1016/j.cclet.2018.05.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
106 Vorherr T. Peptide Therapeutics. Bioorg Med Chem 2018;26:2699. [PMID: 29778135 DOI: 10.1016/j.bmc.2018.05.007] [Reference Citation Analysis]
107 Valeur E, Jimonet P. New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm. J Med Chem 2018;61:9004-29. [DOI: 10.1021/acs.jmedchem.8b00378] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
108 Ben-menahem D. Preparation, characterization and application of long-acting FSH analogs for assisted reproduction. Theriogenology 2018;112:11-7. [DOI: 10.1016/j.theriogenology.2017.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
109 Chen W, Yung BC, Qian Z, Chen X. Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction. Adv Drug Deliv Rev 2018;127:20-34. [PMID: 29391221 DOI: 10.1016/j.addr.2018.01.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
110 Cheang JY, Moyle PM. Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes. ChemMedChem. 2018;13:662-671. [PMID: 29430842 DOI: 10.1002/cmdc.201700781] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
111 Smith WJ, Tran H, Griffin JI, Jones J, Vu VP, Nilewski L, Gianneschi N, Simberg D. Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes. Biomaterials 2018;161:57-68. [PMID: 29421563 DOI: 10.1016/j.biomaterials.2018.01.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
112 Gabe MBN, Sparre-Ulrich AH, Pedersen MF, Gasbjerg LS, Inoue A, Bräuner-Osborne H, Hartmann B, Rosenkilde MM. Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors. Biochem Pharmacol 2018;150:97-107. [PMID: 29378179 DOI: 10.1016/j.bcp.2018.01.040] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
113 Erak M, Bellmann-Sickert K, Els-Heindl S, Beck-Sickinger AG. Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics. Bioorg Med Chem 2018;26:2759-65. [PMID: 29395804 DOI: 10.1016/j.bmc.2018.01.012] [Cited by in Crossref: 125] [Cited by in F6Publishing: 146] [Article Influence: 25.0] [Reference Citation Analysis]
114 Han J, Fei Y, Zhou F, Chen X, Zhang Y, Liu L, Fu J. Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities. Br J Pharmacol 2018;175:544-57. [PMID: 29171021 DOI: 10.1111/bph.14107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
115 Anand R, Vallooran J. Polypeptides. Engineering of Biomaterials for Drug Delivery Systems 2018. [DOI: 10.1016/b978-0-08-101750-0.00011-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
116 Slominskiĭ PA, Shadrina MI. Peptide pharmaceuticals: opportunities, prospects and limitations. Mol genet mikrobiol virusol 2018;36:8. [DOI: 10.18821/0208-0613-2018-36-1-8-14] [Reference Citation Analysis]
117 Han J, Fei Y, Zhou F, Chen X, Zheng W, Fu J. Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes. Mol Pharmaceutics 2017;14:3954-67. [DOI: 10.1021/acs.molpharmaceut.7b00632] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
118 Han J, Chen X, Wang Y, Fei Y, Zhou F, Zhang Y, Liu L, Si P, Fu J. Xenopus GLP-1-inspired discovery of novel GLP-1 receptor agonists as long-acting hypoglycemic and insulinotropic agents with significant therapeutic potential. Biochemical Pharmacology 2017;142:155-67. [DOI: 10.1016/j.bcp.2017.06.132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
119 Zhang Q, Yang M, Sørensen KK, Madsen CS, Boesen JT, An Y, Peng SH, Wei Y, Wang Q, Jensen KJ, Zuo Z, Chan HYE, Ngo JCK. A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases. Sci Rep 2017;7:12077. [PMID: 28935901 DOI: 10.1038/s41598-017-11695-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
120 Haußner C, Lach J, Eichler J. Synthetic antibody mimics for the inhibition of protein-ligand interactions. Curr Opin Chem Biol 2017;40:72-7. [PMID: 28735229 DOI: 10.1016/j.cbpa.2017.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
121 Müller C, Farkas R, Borgna F, Schmid RM, Benešová M, Schibli R. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals. Bioconjugate Chem 2017;28:2372-83. [DOI: 10.1021/acs.bioconjchem.7b00378] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
122 Foster JS, Williams AD, Macy S, Richey T, Stuckey A, Wooliver DC, Koul-Tiwari R, Martin EB, Kennel SJ, Wall JS. A Peptide-Fc Opsonin with Pan-Amyloid Reactivity. Front Immunol 2017;8:1082. [PMID: 28928748 DOI: 10.3389/fimmu.2017.01082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 McBrayer DN, Tal-Gan Y. Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus. Drug Dev Res 2017;78:292-9. [PMID: 28786125 DOI: 10.1002/ddr.21404] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
124 Tornesello AL, Buonaguro L, Tornesello ML, Buonaguro FM. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology. Molecules 2017;22:E1282. [PMID: 28767081 DOI: 10.3390/molecules22081282] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
125 Zorzi A, Middendorp SJ, Wilbs J, Deyle K, Heinis C. Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides. Nat Commun 2017;8:16092. [PMID: 28714475 DOI: 10.1038/ncomms16092] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 13.8] [Reference Citation Analysis]
126 Kovalainen M. Neuromedin peptides-Potential for anti-obesity drug candidates? Peptides 2017;94:106-7. [PMID: 28483480 DOI: 10.1016/j.peptides.2017.05.001] [Reference Citation Analysis]
127 van Witteloostuijn SB, Mannerstedt K, Wismann P, Bech EM, Thygesen MB, Vrang N, Jelsing J, Jensen KJ, Pedersen SL. Neoglycolipids for Prolonging the Effects of Peptides: Self-Assembling Glucagon-like Peptide 1 Analogues with Albumin Binding Properties and Potent in Vivo Efficacy. Mol Pharmaceutics 2017;14:193-205. [DOI: 10.1021/acs.molpharmaceut.6b00787] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]